Skip to main content
. 2021 May 5;30(1):11–16. doi: 10.1136/ejhpharm-2020-002597

Table 3.

Stability of carmustine (Carmustin Obvius, Carmubris) stock solution stored for 48 hours at 2–8°C in the punctured vial and carmustine infusion solutions (0.2 mg/mL, 1.0 mg/mL) diluted in 5% glucose injection solution (freeflex PP/PE bags) stored at 2–8°C for 60 hours±further 6 hours stored at 22°C under light protection

Carmustine-containing medicinal product Initial carmustine concentration
(mg/mL)±RSD (%)
% Initial carmustine concentration remaining±RSD (%) (n=9)
Measured concentration 0 hour=100%
Nominal Measured 12 hours 24 hours 48 hours 60 hours 60+3 hours 60+6 hours
Carmustin Obvius 3.33 3.3707 (±0.57) 98.46 (±1.52) 96.87 (±1.11) 94.02 (±2.31) NA
Carmubris 3.3481 (±0.93) 99.61 (±0.68) 97.89 (±0.47) 95.45 (±0.76)
Carmustin Obvius 0.2 0.2011 (±1.39) 96.84 (±0.60) 95.42 (±0.39) 93.03 (±0.22) 91.95 (±0.40) 89.82 (±0.49) 86.80 (±0.29)
Carmubris 0.1994 (±0.77) 97.79 (±0.28) 96.04 (±0.29) 93.81 (±0.25) 92.57 (±0.42) 91.76 (±1.78) 88.70 (±0.35)
Carmustin Obvius 1.0 0.9649 (±1,00) NA 96.39 (±0.83) 95.47 (±0.56) 93.07 (±0.67) NA

The remaining carmustine concentration is expressed as mean±RSD percentage rate (%) of nine measurements per time point (n=9).

NA, not applicable; RSD, relative standard deviation.